Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Articles by : Bella Czajkowski, National Correspondent
An influential 340B hospital advocacy group has launched a new ad blitz warning against proposed changes to the 340B program [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In an 180-degree change from his first term in the White House, President-elect Donald Trump (R) late Thursday nominated Robert [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmakers AbbVie and GlaxoSmithKline (GSK) will refund 340B providers for some products following ceiling price recalculations, according to notices posted [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Supreme Court heard arguments Tuesday on a case challenging a federal rule over disproportionate share hospital (DSH) calculations [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Eli Lilly announced that it will refund 340B covered entities that purchased certain medications following adjustments to their ceiling prices. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations, according to notices [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year, [...] …
